ICD Firms’ Investors See Promise In Coverage Expansion – MDDI Index
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical's potential to leverage expanded Medicare coverage of implantable cardioverter defibrillators, set for finalization by year-end, helped buoy the firm's stock price in the third quarter
You may also be interested in...
Defib Data Will Provide Different Opportunities For Medtronic, CMS
Medtronic appears intent to use data collected from ongoing studies and patient registries on cardiac resynchronization therapies to shift the heart failure treatment paradigm from drugs toward devices
Defib Data Will Provide Different Opportunities For Medtronic, CMS
Medtronic appears intent to use data collected from ongoing studies and patient registries on cardiac resynchronization therapies to shift the heart failure treatment paradigm from drugs toward devices
ArthroCare Tonsillectomy Potential, Opus Buy Boost Stock 22% In September
ArthroCare Coblation technology uptake for tonsillectomy procedures and accelerated sports medicine growth aided a 22% increase in the firm's stock price in September - up $5.29 to $29.29